Compare BIO & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | AROC |
|---|---|---|
| Founded | 1952 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil & Gas Production |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.5B |
| IPO Year | 1994 | 2007 |
| Metric | BIO | AROC |
|---|---|---|
| Price | $357.53 | $34.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $339.75 | $40.00 |
| AVG Volume (30 Days) | 293.3K | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | ★ 142.61 | 74.29 |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $2,583,200,000.00 | $1,489,818,000.00 |
| Revenue This Year | $2.74 | $7.06 |
| Revenue Next Year | $3.20 | $5.27 |
| P/E Ratio | ★ N/A | $42.24 |
| Revenue Growth | 0.65 | ★ 28.70 |
| 52 Week Low | $236.73 | $22.88 |
| 52 Week High | $365.00 | $42.23 |
| Indicator | BIO | AROC |
|---|---|---|
| Relative Strength Index (RSI) | 72.62 | 45.02 |
| Support Level | $289.16 | $33.07 |
| Resistance Level | N/A | $37.33 |
| Average True Range (ATR) | 12.24 | 1.10 |
| MACD | 2.07 | -0.08 |
| Stochastic Oscillator | 85.10 | 52.96 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.